GRHL2-miR-200-ZEB1 maintains the epithelial status of ovarian cancer through transcriptional regulation and histone modification

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Chung, Vin Yee ^a   Tan, Tuan Zea ^a   Tan, Ming ^a   Wong, Meng Kang ^a   Kuay, Kuee Theng ^a   Yang, Zhe ^a   Ye, Jieru ^a   Muller, Julius ^b   Koh, Cheryl M ^b   Guccione, Ernesto ^b   Thiery, Jean Paul ^a,b,c   Huang, Ruby Yun Ju ^a,c,d  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b INSTITUTE OF MOLECULAR AND CELL BIOLOGY   (Singapore)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^d NATIONAL UNIVERSITY HOSPITAL   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

DNA BINDING PROTEIN; GRHL2 PROTEIN, HUMAN; HISTONE; MICRORNA; MIRN200 MICRORNA, HUMAN; RNA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ZEB1; TUMOR PROTEIN; ZEB1 PROTEIN, HUMAN;

DNA RESPONSIVE ELEMENT; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; GENETIC TRANSCRIPTION; GENETICS; HUMAN; METABOLISM; OVARY TUMOR; PATHOLOGY; PROTEIN PROCESSING; TUMOR CELL LINE;

CELL LINE, TUMOR; DNA-BINDING PROTEINS; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; HISTONES; HUMANS; MICRORNAS; NEOPLASM PROTEINS; OVARIAN NEOPLASMS; PROTEIN PROCESSING, POST-TRANSLATIONAL; RESPONSE ELEMENTS; RNA, NEOPLASM; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; ZINC FINGER E-BOX-BINDING HOMEOBOX 1;

EID: 84959019506     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep19943     Document Type: Article

References (56)

1. Thiery, J. P. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer. 2, 442-454 (2002).
2. Ahmed, N., Thompson, E. W., Quinn, M. A. Epithelial-mesenchymal interconversions in normal ovarian surface epithelium and ovarian carcinomas: an exception to the norm. J Cell Physiol. 213, 581-588 (2007).
3. Huang, R. Y. J., Chung, V. Y., Thiery, J. P. Targeting pathways contributing to epithelial-mesenchymal transition (EMT) in epithelial ovarian cancer. Curr Drug Targets. 13, 1649-1653 (2012).
4. Kurrey, N. K., K, A., Bapat, S. A. Snail and Slug are major determinants of ovarian cancer invasiveness at the transcription level. Gynecol Oncol. 97, 155-165 (2005).
5. Ponnusamy, M. P. et al. MUC4 mucin-induced epithelial to mesenchymal transition: a novel mechanism for metastasis of human ovarian cancer cells. Oncogene. 29, 5741-5754 (2010).
6. Wang, Y. et al. CUL4A induces epithelial-mesenchymal transition and promotes cancer metastasis by regulating ZEB1 expression. Cancer Res. 74, 520-531 (2014).
7. Wu, Q., Guo, R., Lin, M., Zhou, B., Wang, Y. MicroRNA-200a inhibits CD133/1+ ovarian cancer stem cells migration and invasion by targeting E-cadherin repressor ZEB2. Gynecol Oncol. 122, 149-154 (2011).
8. Thiery, J. P., Acloque, H., Huang, R. Y. J., Nieto, M. A. Epithelial-mesenchymal transitions in development and disease. Cell. 139, 871-890 (2009).
9. Huang, R. Y. J. et al. An EMT spectrum defines an anoikis-resistant and spheroidogenic intermediate mesenchymal state that is sensitive to e-cadherin restoration by a src-kinase inhibitor, saracatinib (AZD0530). Cell Death Dis. 4, e915 (2013).
10. Wilanowski, T. et al. A highly conserved novel family of mammalian developmental transcription factors related to Drosophila grainyhead. Mech Dev. 114, 37-50 (2002).
11. Wilanowski, T. et al. Perturbed desmosomal cadherin expression in grainy head-like 1-null mice. EMBO J. 27, 886-897 (2008).
12. Werth, M. et al. The transcription factor grainyhead-like 2 regulates the molecular composition of the epithelial apical junctional complex. Development. 137, 3835-3845 (2010).
13. Ting, S. B. et al. Inositol-and folate-resistant neural tube defects in mice lacking the epithelial-specific factor Grhl-3. Nat Med. 9, 1513-1519 (2003).
14. Senga, K., Mostov, K. E., Mitaka, T., Miyajima, A., Tanimizu, N. Grainyhead-like 2 regulates epithelial morphogenesis by establishing functional tight junctions through the organization of a molecular network among claudin3, claudin4, and Rab25. Mol Biol Cell. 23, 2845-2855 (2012).
15. Varma, S. et al. The transcription factors Grainyhead-like 2 and NK2-homeobox 1 form a regulatory loop that coordinates lung epithelial cell morphogenesis and differentiation. J Biol Chem. 287, 37282-37295 (2012).
16. Han, Y. et al. Grhl2 deficiency impairs otic development and hearing ability in a zebrafish model of the progressive dominant hearing loss DFNA28. Hum Mol Genet. 20, 3213-3226 (2011).
17. Gao, X. et al. Evidence for multiple roles for grainyheadlike 2 in the establishment and maintenance of human mucociliary airway epithelium. Proc Natl Acad Sci USA 110, 9356-9361 (2013).
18. Kang, X., Chen, W., Kim, R. H., Kang, M. K., Park, N. H. Regulation of the hTERT promoter activity by MSH2, the hnRNPs K and D, and GRHL2 in human oral squamous cell carcinoma cells. Oncogene. 28, 565-574 (2009).
19. Cieply, B. et al. Suppression of the epithelial-mesenchymal transition by Grainyhead-like-2. Cancer Res. 72, 2440-2453 (2012).
20. Cieply, B., Farris, J., Denvir, J., Ford, H., Frisch, S. M. A reciprocal feedback loop between Grainyhead-like-2 and ZEB1 controls EMT and tumor suppression. Cancer Res. 73, 6299-6309 (2013).
21. Werner, S. et al. Dual Roles of the Transcription Factor Grainyhead-like 2 (GRHL2) in Breast Cancer. J Biol Chem. 288, 22993-23008 (2013).
22. Xiang, X. et al. Grhl2 determines the epithelial phenotype of breast cancers and promotes tumor progression. PLoS One. 7, e50781 (2012).
23. Yang, X., Vasudevan, P., Parekh, V., Penev, A., Cunningham, J. M. Bridging cancer biology with the clinic: relative expression of a GRHL2-mediated gene-set pair predicts breast cancer metastasis. PLoS One. 8, e56195 (2013).
24. Xiang, J. et al. Expression and role of grainyhead-like 2 in gastric cancer. Med Oncol. 30, 714 (2013).
25. Quan, Y. et al. Downregulation of GRHL2 inhibits the proliferation of colorectal cancer cells by targeting ZEB1. Cancer Biol Ther. 15, 878-887 (2014).
26. Tanaka, Y. et al. Gain of GRHL2 is associated with early recurrence of hepatocellular carcinoma. J Hepatol. 49, 746-757 (2008).
27. Dompe, N. et al. A whole-genome RNAi screen identifies an 8q22 gene cluster that inhibits death receptor-mediated apoptosis. Proc Natl Acad Sci USA 108, E943-E951 (2011).
28. Cerami, E. et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2, 401-404 (2012).
29. Gao, J. et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal. 6, pl1 (2013).
30. Tan, T. Z. et al. Epithelial-mesenchymal transition spectrum quantification and its efficacy in deciphering survival and drug responses of cancer patients. EMBO Mol Med. 6, 1279-1293 (2014).
31. Barretina, J. et al. The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature. 483, 603-607 (2012).
32. Tan, T. Z. et al. Functional genomics identifies five distinct molecular subtypes with clinical relevance and pathways for growth control in epithelial ovarian cancer. EMBO Mol Med. 5, 983-998 (2013).
33. Verhaak, R. G. W. et al. Prognostically relevant gene signatures of high-grade serous ovarian carcinoma. J Clin Invest. 123, 517-525 (2013).
34. Miow, Q. H. et al. Epithelial-mesenchymal status renders differential responses to cisplatin in ovarian cancer. Oncogene. 34, 1899-1907 (2014).
35. Hidalgo-Carcedo, C. et al. Collective cell migration requires suppression of actomyosin at cell-cell contacts mediated by DDR1 and the cell polarity regulators Par3 and Par6. Nat Cell Biol. 13, 49-58 (2011).
36. Zhang, Y. et al. Model-based analysis of ChIP-Seq (MACS). Genome Biol. 9, R137 (2008).
37. Boglev, Y. et al. The unique and cooperative roles of the Grainy head-like transcription factors in epidermal development reflect unexpected target gene specificity. Dev Biol. 349, 512-522 (2011).
38. Chen, W. et al. Grainyhead-like 2 enhances the human telomerase reverse transcriptase gene expression by inhibiting DNA methylation at the 5?-CpG island in normal human keratinocytes. J Biol Chem. 285, 40852-40863 (2010).
39. Kokoszynska, K., Ostrowski, J., Rychlewski, L., Wyrwicz, L. S. The fold recognition of CP2 transcription factors gives new insights into the function and evolution of tumor suppressor protein p53. Cell Cycle. 7, 2907-2915 (2008).
40. Riethdorf, S. et al. Diverse expression patterns of the EMT suppressor grainyhead-like 2 (GRHL2) in normal and tumour tissues. Int J Cancer. [Epub ahead of print] (2015).
41. Bracken, C. P. et al. A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelialmesenchymal transition. Cancer Res. 68, 7846-7854 (2008).
42. Gregory, P. A. et al. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol. 10, 593-601 (2008).
43. Moes, M. et al. A novel network integrating a miRNA-203/SNAI1 feedback loop which regulates epithelial to mesenchymal transition. PLoS One. 7, e35440 (2012).
44. Brabletz, S., Brabletz, T. The ZEB/miR-200 feedback loop-a motor of cellular plasticity in development and cancer? EMBO Rep. 11, 670-677 (2010).
45. Chen, W. et al. Grainyhead-like 2 (GRHL2) inhibits keratinocyte differentiation through epigenetic mechanism. Cell Death Dis. 3, e450 (2012).
46. Varma, S. et al. Grainyhead-like 2 (GRHL2) distribution reveals novel pathophysiological differences between human idiopathic pulmonary fibrosis and mouse models of pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol. 306, L405-L419 (2014).
47. Leth-Larsen, R. et al. Functional heterogeneity within the CD44 high human breast cancer stem cell-like compartment reveals a gene signature predictive of distant metastasis. Mol Med. 18, 1109-1121 (2012).
48. Bracken, C. P. et al. Genome-wide identification of miR-200 targets reveals a regulatory network controlling cell invasion. EMBO J. 33, 2040-2056 (2014).
49. Li, X. et al. MiR-200 can repress breast cancer metastasis through ZEB1-independent but moesin-dependent pathways. Oncogene. 33, 4077-4088 (2014).
50. Carmona, F. J. et al. A Comprehensive DNA Methylation Profile of Epithelial-to-Mesenchymal Transition. Cancer Res. 74, 5608-5619 (2014).
51. Huang, R. Y. J. et al. Functional relevance of a six mesenchymal gene signature in epithelial-mesenchymal transition (EMT) reversal by the triple angiokinase inhibitor, nintedanib (BIBF1120). Oncotarget. 6, 22098-22113 (2015).
52. Huang, R. Y. et al. Histotype-specific copy-number alterations in ovarian cancer. BMC Med Genomics. 5, 47 (2012).
53. Langmead, B., Salzberg, S. L. Fast gapped-read alignment with Bowtie 2. Nat Methods. 9, 357-359 (2012).
54. Machanick, P., Bailey, T. L. MEME-ChIP: motif analysis of large DNA datasets. Bioinformatics. 27, 1696-1697 (2011).
55. Heinz, S. et al. Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol Cell. 38, 576-589 (2010).
56. Mathelier, A. et al. JASPAR 2014: an extensively expanded and updated open-access database of transcription factor binding profiles. Nucleic Acids Res. 42, D142-D147 (2014).